AIG
WINT

American International Group’s Windtree Therapeutics Inc WINT Stock Holding History

American International Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-130
Closed – – 4913
2016
Q1 		$0 Sell
130
-1
-0.8% -$2 ﹤0.01% 5201
2015
Q4 		$0 Hold
131
– – ﹤0.01% 5155
2015
Q3 		$0 Buy
131
+70
+115% +$463 ﹤0.01% 5138
2015
Q2 		$577 Buy
61
+36
+144% +$506 ﹤0.01% 5015
2015
Q1 		$415 Hold
25
– – ﹤0.01% 4970
2014
Q4 		$405 Hold
25
– – ﹤0.01% 4938
2014
Q3 		$642 Buy
25
+1
+4% +$24 ﹤0.01% 4921
2014
Q2 		$593 Hold
24
– – ﹤0.01% 4870
2014
Q1 		$716 Hold
24
– – ﹤0.01% 4766
2013
Q4 		$749 Hold
24
– – ﹤0.01% 4698
2013
Q3 		$653 Sell
24
-2,134
-99% -$51.7K ﹤0.01% 4605
2013
Q2 		$45.9K Buy
+2,158
New +$53.2K ﹤0.01% 3612

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's WINT Position: Q2 2016 in Review

American International Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2016, closing a stake of 130 shares.

American International Group first reported a position in WINT in Q2 2013 and held it in 12 quarters. The position peaked at $45.9K in Q2 2013. 33 funds tracked by Wall St. Rank hold WINT as of Q2 2016.

  • American International Group reported no remaining Windtree Therapeutics Inc position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 130 Windtree Therapeutics Inc shares in Q2 2016.
  • American International Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 12 quarters.
  • American International Group's Windtree Therapeutics Inc position peaked at $45.9K in Q2 2013.
  • 33 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.